《盈警》和铂医药(02142.HK)料上半年溢利按年减少48.3%至65.5%

阿斯达克财经07-19

和铂医药(02142.HK) 发盈警，预期上半年溢利将介乎100万至150万美元，与去年同期溢利约290万美元相比，按年减少约48.3%至65.5%，主要由于收入结构变动所致。尤其是期内来自服务业务的收费占总收入的比例较去年上半年的收入有所增加。然而，相较于去年上半年收入中占较大比例的授权收入，该类收入的利润率相对较薄。因此，今年上半年的整体溢利有所减少。

过往派息

公布日期	派息事项	派息内容
2024/03/28	末期业绩	无派息
2023/08/28	中期业绩	无派息
2023/03/29	末期业绩	无派息
2022/08/31	中期业绩	无派息

公司强调，上半年从其现有管线中已实现授权及合作的创新项目中获得里程碑付款，对收入作出重大贡献；今年公司加快其业务拓展，上半年订立的新授权及合作带动其经营业绩持续增长；加强业务营运成本控制的一贯策略，故预期上半年将维持整体溢利。(jl/cy)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2452464267?lang=zh_CN&edition=full","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210504112141597_s.jpg","is_english":false,"pubTime":"2024-07-19 08:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2452464267","market":"fut","top_or_hot":-1,"title":"《盈警》和铂医药(02142.HK)料上半年溢利按年减少48.3%至65.5%","media":"阿斯达克财经","content":"<html><body><div> <span> <p>和铂医药(02142.HK)<span> </span>发盈警，预期上半年溢利将介乎100万至150万美元，与去年同期溢利约290万美元相比，按年减少约48.3%至65.5%，主要由于收入结构变动所致。尤其是期内来自服务业务的收费占总收入的比例较去年上半年的收入有所增加。然而，相较于去年上半年收入中占较大比例的授权收入，该类收入的利润率相对较薄。因此，今年上半年的整体溢利有所减少。<br/></p><div><div><div>过往派息</div><div><div></div></div><div><table><thead><tr><th>公布日期</th><th>派息事项</th><th>派息内容</th></tr></thead><tbody><tr><td>2024/03/28</td><td>末期业绩</td><td>无派息</td></tr><tr><td>2023/08/28</td><td>中期业绩</td><td>无派息</td></tr><tr><td>2023/03/29</td><td>末期业绩</td><td>无派息 </td></tr><tr><td>2022/08/31</td><td>中期业绩</td><td>无派息 </td></tr></tbody></table></div></div></div><br/>公司强调，上半年从其现有管线中已实现授权及合作的创新项目中获得里程碑付款，对收入作出重大贡献；今年公司加快其业务拓展，上半年订立的新授权及合作带动其经营业绩持续增长；加强业务营运成本控制的一贯策略，故预期上半年将维持整体溢利。(jl/cy)(港股报价延迟最少十五分钟。)<div></div>AASTOCKS新闻 </span> </div></body></html>","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《盈警》和铂医药(02142.HK)料上半年溢利按年减少48.3%至65.5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《盈警》和铂医药(02142.HK)料上半年溢利按年减少48.3%至65.5%\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">阿斯达克财经</strong><span class=\"h-time small\">2024-07-19 08:13</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><div> <span> <p>和铂医药(02142.HK)<span> </span>发盈警，预期上半年溢利将介乎100万至150万美元，与去年同期溢利约290万美元相比，按年减少约48.3%至65.5%，主要由于收入结构变动所致。尤其是期内来自服务业务的收费占总收入的比例较去年上半年的收入有所增加。然而，相较于去年上半年收入中占较大比例的授权收入，该类收入的利润率相对较薄。因此，今年上半年的整体溢利有所减少。<br/></p><div><div><div>过往派息</div><div><div></div></div><div><table><thead><tr><th>公布日期</th><th>派息事项</th><th>派息内容</th></tr></thead><tbody><tr><td>2024/03/28</td><td>末期业绩</td><td>无派息</td></tr><tr><td>2023/08/28</td><td>中期业绩</td><td>无派息</td></tr><tr><td>2023/03/29</td><td>末期业绩</td><td>无派息 </td></tr><tr><td>2022/08/31</td><td>中期业绩</td><td>无派息 </td></tr></tbody></table></div></div></div><br/>公司强调，上半年从其现有管线中已实现授权及合作的创新项目中获得里程碑付款，对收入作出重大贡献；今年公司加快其业务拓展，上半年订立的新授权及合作带动其经营业绩持续增长；加强业务营运成本控制的一贯策略，故预期上半年将维持整体溢利。(jl/cy)(港股报价延迟最少十五分钟。)<div></div>AASTOCKS新闻 </span> </div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1364765/latest-news/AAFN\">阿斯达克财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1364765/latest-news/AAFN","article_id":"2452464267","we_media_id":null,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210504112141597_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2452464267","pubTimestamp":1721347980,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"和铂医药发盈警，预期上半年溢利将介乎100万至150万美元，与去年同期溢利约290万美元相比，按年减少约48.3%至65.5%，主要由于收入结构变动所致。尤其是期内来自服务业务的收费占总收入的比例较去年上半年的收入有所增加。然而，相较于去年上半年收入中占较大比例的授权收入，该类收入的利润率相对较薄。因此，今年上半年的整体溢利有所减少。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02142":"和铂医药-B","BK1574":"生物医药B类股","BK1583":"高瓴概念","BK1161":"生物科技"},"translate_title":"\"Profit Warning\" Hebo Pharmaceuticals (02142. HK) expects first-half profit to decrease by 48.3% year-on-year to 65.5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"和铂医药(02142.HK) 发盈警，预期上半年溢利将介乎100万至150万美元，与去年同期溢利约290万美元相比，按年减少约48.3%至65.5%，主要由于收入结构变动所致。尤其是期内来自服务业务的收费占总收入的比例较去年上半年的收入有所增加。然而，相较于去年上半年收入中占较大比例的授权收入，该类收入的利润率相对较薄。因此，今年上半年的整体溢利有所减少。过往派息公布日期派息事项派息内容2024/03/28末期业绩无派息2023/08/28中期业绩无派息2023/03/29末期业绩无派息 2022/08/31中期业绩无派息 公司强调，上半年从其现有管线中已实现授权及合作的创新项目中获得里程碑付款，对收入作出重大贡献；今年公司加快其业务拓展，上半年订立的新授权及合作带动其经营业绩持续增长；加强业务营运成本控制的一贯策略，故预期上半年将维持整体溢利。(jl/cy)(港股报价延迟最少十五分钟。)AASTOCKS新闻","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2452464267"}